Nicotinic mechanisms influencing synaptic plasticity in the hippocampus

Acta Pharmacologica Sinica

Volumn 30, Issue 6, 2009, Pages 752-760

  Placzek, Andon Nicholas ^a   Zhang, Tao A ^a   Dani, John Anthony ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Long term depression; Long term potentiation; Nicotine addiction; Nicotinic acetylcholine receptors; Tobacco addiction

Indexed keywords

AMFEBUTAMONE; NICOTINE; NICOTINE GUM; NICOTINIC RECEPTOR; VARENICLINE;

BRAIN NERVE CELL; DENDRITE; DEPRESSION; DRUG MECHANISM; HIPPOCAMPUS; HUMAN; LEARNING; LONG TERM DEPRESSION; LONG TERM POTENTIATION; MEMORY; NERVE CELL PLASTICITY; NERVE PROJECTION; NEUROTRANSMITTER RELEASE; NICOTINE REPLACEMENT THERAPY; PRESYNAPTIC NERVE; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SYNAPSE; TOBACCO DEPENDENCE; WITHDRAWAL SYNDROME;

ANIMALS; HIPPOCAMPUS; HUMANS; NEURONAL PLASTICITY; NICOTINE; NICOTINIC AGONISTS; PROTEIN SUBUNITS; RECEPTORS, NICOTINIC; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; TOBACCO USE DISORDER;

EID: 67549101178     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2009.39     Document Type: Review

References (89)

1. Alkondon M, Albuquerque EX. The nicotinic acetylcholine receptor subtypes and their function in the hippocampus and cerebral cortex. Prog Brain Res 2004; 145: 109-20
2. Liu Z, Zhang J, Berg DK. Role of endogenous nicotinic signaling in guiding neuronal development. Biochem Pharmacol 2007; 74: 1112-9.
3. Dani JA, Bertrand D. Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu Rev Pharmacol Toxicol 2007; 47: 699-729.
4. Kenney JW, Gould TJ. Modulation of hippocampus-dependent learning and synaptic plasticity by nicotine. Mol Neurobiol 2008; 38: 101-21.
5. Albuquerque EX, Pereira EF, Alkondon M, Rogers SW. Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol Rev 2009; 89: 73-120.
6. Millar NS, Goti C. Diversity of vertebrate nicotinic acetylcholine receptors. Neuropharmacology 2009; 56: 237-46.
7. Sharma G, Vijayaraghavan S. Nicotinic receptor signaling in nonexcitable cells. J Neurobiol 2002; 53: 524-34.
8. Kasa P. The cholinergic systems in brain and spinal cord. Prog Neurobiol 1986; 26: 211-72.
9. Woolf NJ. Cholinergic systems in mammalian brain and spinal cord. Prog Neurobiol 1991; 37: 475-524.
10. Hef S, Hulo S, Bertrand D, Muller D. Synaptic transmission at nicotinic acetylcholine receptors in rat hippocampal organotypic cultures and slices. J Physiol 1999; 515: 769-76.
11. Descarries L, Gisiger V, Steriade M. Diffuse transmission by acetylcholine in the CNS. Prog Neurobiol 1997; 53: 603-25.
12. Alonso JR, Amaral DG. Cholinergic innervation of the primate hippocampal formation. I. Distribution of choline acetyl trans-ferase immunoreactivity in the Macaca fascicularis and Macaca mulata monkeys. J Compar Neurol 1995; 355: 135-70.
13. Yoshida K, Oka H. Topographical projections from the medial septum-diagonal band complex to the hippocampus: a retrograde tracing study with multiple fuorescent dyes in rats. Neurosci Res 1995; 21: 199-209.
14. Auld DS, Kornecook TJ, Bastianetto S, Quirion R. Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies. Prog Neurobiol 2002; 68: 209-45.
15. Wada E, Wada K, Boulter J, Deneris E, Heinemann S, Patrick J, et al. Distribution of alpha 2, alpha 3, alpha 4, and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat. J Compar Neurol 1989; 284: 314-35.
16. Albuquerque EX, Alkondon M, Pereira EF, Castro NG, Schrat-tenholz A, Barbosa CT, et al. Properties of neuronal nicotinic acetylcholine receptors: pharmacological characterization and modu lation of synaptic function. J Pharmacol Exp Ther 1997; 280: 1117-36.
17. Tribollet E, Bertrand D, Marguerat A, Raggenbass M. Comparative distribution of nicotinic receptor subtypes during development, adulthood and aging: an autoradiographic study in the rat brain. Neuroscience 2004;124: 405-20.
18. 125I]-alpha-bungarotoxin. J Neurosci 1985; 5: 1307-15.
19. Court JA, Lloyd S, Johnson M, Griffiths M, Birdsall NJ, Piggott MA, et al. Nicotinic and muscarinic cholinergic receptor binding in the human hippocampal formation during development and aging. Brain Res Dev Brain Res 1997; 101: 93-105.
20. Deneris ES, Connolly J, Boulter J, Wada E, Wada K, Swanson LW, et al. Primary structure and expression of beta 2: a novel subunit of neuronal nicotinic acetylcholine receptors. Neuron 1988; 1: 45-54.
21. Dineley-Miller K, Patrick J. Gene transcripts for the nicotinic acetylcholine receptor subunit, beta4, are distributed in multiple areas of the rat central nervous system. Brain Res Mol Brain Res 1992; 16: 339-44.
22. Marks MJ, Pauly JR, Gross SD, Deneris ES, Hermans-Borgmeyer I, Heinemann SF, et al. Nicotine binding and nicotinic receptor subunit RNA afer chronic nicotine treatment. J Neurosci 1992; 12: 2765-84.
23. Marks MJ, Pauly JR, Grun EU, Collins AC. ST/b and DBA/2 mice differ in brain alpha-bungarotoxin binding and alpha 7 nicotinic receptor subunit mRNA levels: a quantitative autoradiographic analysis. Brain Res Mol Brain Res 1996; 39: 207-22.
24. Seguela P, Wadiche J, Dineley-Miller K, Dani JA, Patrick JW. Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium. J Neurosci 1993; 13: 596-604.
25. Wada E, McKinnon D, Heinemann S, Patrick J, Swanson LW. Te distribution of mRNA encoded by a new member of the neuronal nicotinic acetylcholine receptor gene family (alpha 5) in the rat central nervous system. Brain Res 1990; 526: 45-53.
26. Zarei MM, Radclife K, Chen D, Patrick JW, Dani JA. Distributions of nicotinic acetylcholine receptor alpha7 and beta2 subunits on cultured hippocampal neurons. Neuroscience 1999; 88: 755- 64.
27. Hellstrom-Lindahl E, Mousavi M, Zhang X, Ravid R, Nordberg A. Regional distribution of nicotinic receptor subunit mRNAs in human brain: comparison between Alzheimer and normal brain. Brain Res Mol Brain Res 1999; 66: 94-103.
28. Graham AJ, Ray MA, Perry EK, Jaros E, Perry RH, Volsen SG, et al. Diferential nicotinic acetylcholine receptor subunit expression in the human hippocampus. J Chem Neuroanat 2003; 25: 97-113.
29. Alkondon M, Pereira EF, Albuquerque EX. Mapping the location of functional nicotinic and gamma-aminobutyric acid A receptors on hippocampal neurons. J Pharmacol Exp Ter 1996; 279: 1491- 506.
30. Gray R, Rajan AS, Radcliffe KA, Yakehiro M, Dani JA. Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature 1996; 383:713-6.
31. Fabian-Fine R, Skehel P, Errington ML, Davies HA, Sher E, Stewart MG, et al. Ultrastructural distribution of the alpha7 nico tinic acetylcholine receptor subunit in rat hippocampus. J Neurosci 2001; 21: 7993-8003.
32. 2+ regulation of nicotinic acetylcholine receptor channels in rat hippocampal CA1 neurons. J Neurosci 2003; 23: 9024-31.
33. Yakel JL, Shao Z. Functional and molecular characterization of neuronal nicotinic ACh receptors in rat hippocampal interneurons. Prog Brain Res 2004;145: 95-107.
34. Wonnacott S. Presynaptic nicotinic ACh receptors. Trends Neurosci 1997; 20: 92-8.
35. MacDermott AB, Role LW, Siegelbaum SA. Presynaptic iono-tropic receptors and the control of transmiter release. Annu Rev Neurosci 1999; 22: 443-85.
36. McKay BE, Placzek AN, Dani JA. Regulation of synaptic transmission and plasticity by neuronal nicotinic acetylcholine receptors. Biochem Pharmacol 2007; 74: 1120-33.
37. Alkondon M, Rocha ES, Maelicke A, Albuquerque EX. Diversity of nicotinic acetylcholine receptors in rat brain. V. alpha-Bungaro-toxin-sensitive nicotinic receptors in olfactory bulb neurons and presynaptic modulation of glutamate release. J Pharmacol Exp Ter 1996; 278: 1460-71.
38. Role LW, Berg DK. Nicotinic receptors in the development and modulation of CNS synapses. Neuron 1996; 16: 1077-85.
39. Jones S, Sudweeks S, Yakel JL. Nicotinic receptors in the brain: correlating physiology with function. Trends Neurosci 1999; 22: 555-61.
40. Radclife K, Fisher JL, Gray R, Dani JA. Nicotinic modulation of glutamate and GABA synaptic transmission of hippocampal neurons. Ann N Y Acad Sci 1999; 868: 591-610.
41. Ji D, Lape R, Dani JA. Timing and location of nicotinic activity enhances or depresses hippocampal synaptic plasticity. Neuron 2001; 31: 131-41.
42. Ge S, Dani JA. Nicotinic acetylcholine receptors at glutamate synapses facilitate long-term depression or potentiation. J Neurosci 2005; 25: 6084-91.
43. McGehee DS, Role LW. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu Rev Physiol 1995; 57: 521-46.
44. 2+ signals and neurotransmiter release. Mol Pharmacol 2003; 64: 1217-26.
45. Rathouz MM, Vijayaraghavan S, Berg DK. Acetylcholine diferen-tially affects intracellular calcium via nicotinic and muscarinic receptors on the same population of neurons. J Biol Chem 1995; 270: 14366-75.
46. Rathouz MM, Vijayaraghavan S, Berg DK. Elevation of intra-cellular calcium levels in neurons by nicotinic acetylcholine receptors. Mol Neurobiol 1996; 12: 117-31.
47. Sharma G, Vijayaraghavan S. Modulation of presynaptic store calcium induces release of glutamate and postsynaptic fring. Neuron 2003; 38: 929-39.
48. Frazier CJ, Buhler AV, Weiner JL, Dunwiddie TV. Synaptic potentials mediated via alpha-bungarotoxin-sensitive nicotinic acetyl choline receptors in rat hippocampal interneurons. J Neurosci 1998;18: 8228-35.
49. Orr-Urtreger A, Goldner FM, Saeki M, Lorenzo I, Goldberg L, De Biasi M, et al. Mice defcient in the alpha7 neuronal nicotinic acetylcholine receptor lack alpha-bungarotoxin binding sites and hippocampal fast nicotinic currents. J Neurosci 1997;17: 9165-71.
50. Umbriaco D, Garcia S, Beaulieu C, Descarries L. Relational features of acetylcholine, noradrenaline, serotonin and GABA axon terminals in the stratum radiatum of adult rat hippocampus (CA1). Hippocampus 1995; 5: 605-20.
51. Papke RL, Bencherif M, Lippiello P. An evaluation of neuronal nicotinic acetylcholine receptor activation by quaternary nitrogen compounds indicates that choline is selective for the alpha 7 subtype. Neurosci Let 1996; 213: 201-4.
52. Alkondon M, Pereira EF, Cortes WS, Maelicke A, Albuquerque EX. Choline is a selective agonist of alpha7 nicotinic acetylcholine receptors in the rat brain neurons. Eur J Neurosci 1997; 9: 2734- 42.
53. Uteshev VV, Meyer EM, Papke RL. Regulation of neuronal function by choline and 4OH-GTS-21 through alpha 7 nicotinic receptors. J Neurophysiol 2003; 89:1797-806.
54. Ji D, Dani JA. Inhibition and disinhibition of pyramidal neurons by activation of nicotinic receptors on hippocampal interneurons. J Neurophysiol 2000; 83: 2682-90.
55. Alkondon M, Albuquerque EX. Nicotinic acetylcholine receptor alpha7 and alpha4beta2 subtypes diferentially control GABAergic input to CA1 neurons in rat hippocampus. J Neurophysiol 2001; 86: 3043-55.
56. Alkondon M, Pereira EF, Albuquerque EX. alpha-bungarotoxin-and methyllycaconitine-sensitive nicotinic receptors mediate fast synaptic transmission in interneurons of rat hippocampal slices. Brain Res 1998; 810: 257-63.
57. Mansvelder HD, McGehee DS. Long-term potentiation of excitatory inputs to brain reward areas by nicotine. Neuron 2000; 27: 349-57.
58. Dani JA, Ji D, Zhou FM. Synaptic plasticity and nicotine addiction. Neuron 2001; 31: 349-52.
59. Pidoplichko VI, Dani JA. Applying small quantities of multiple compounds to defned locations of in vitro brain slices. J Neurosci Methods 2005;142: 55-66.
60. 2+ entry in melanotropic cells. J Neurophysiol 2002; 87: 793-801.
61. Fenster CP, Whitworth TL, Shefeld EB, Quick MW, Lester R. Upregulation of surface alpha4beta2 nicotinic receptors is initiated by receptor desensitization after chronic exposure to nicotine. J Neurosci 1999; 19: 4804-14.
62. Wooltorton JR, Pidoplichko VI, Broide RS, Dani JA. Diferential desensitization and distribution of nicotinic acetylcholine receptor subtypes in midbrain dopamine areas. J Neurosci 2003; 23: 3176- 85.
63. Hasselmo ME. Te role of acetylcholine in learning and memory. Curr Opin Neurobiol 2006; 16: 710-5.
64. Levin ED, McClernon FJ, Rezvani AH. Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology (Berl) 2006; 184: 523-39.
65. Levin ED, Kim P, Meray R. Chronic nicotine working and reference memory efects in the 16-arm radial maze: interactions with D1 agonist and antagonist drugs. Psychopharmacology (Berl) 1996; 127: 25-30.
66. Levin ED, Kaplan S, Boardman A. Acute nicotine interactions with nicotinic and muscarinic antagonists: working and reference memory efects in the 16-arm radial maze. Behav Pharmacol 1997; 8: 236-42.
67. Levin ED, Bradley A, Addy N, Sigurani N. Hippocampal alpha 7 and alpha 4 beta 2 nicotinic receptors and working memory. Neuroscience 2002; 109: 757-65.
68. Not A, Levin ED. Dorsal hippocampal alpha7 and alpha4beta2 nicotinic receptors and memory. Brain Res 2006; 1081: 72-8.
69. Levin ED, Simon BB. Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology (Berl) 1998; 138: 217-30.
70. Levin ED, Torry D. Acute and chronic nicotine efects on working memory in aged rats. Psychopharmacology (Berl) 1996; 123: 88-97.
71. Socci DJ, Sanberg PR, Arendash GW. Nicotine enhances Morris water maze performance of young and aged rats. Neurobiol Aging 1995; 16: 857-60.
72. Song C, Murray TA, Kimura R, Wakui M, Ellsworth K, Javedan SP, et al. Role of alpha7-nicotinic acetylcholine receptors in tetanic stimulation-induced gamma oscillations in rat hippocampal slices. Neuropharmacology 2005; 48: 869-80.
73. Malenka RC, Bear MF. LTP and LTD: an embarrassment of riches. Neuron 2004; 44: 5-21.
74. Martin SJ, Grimwood PD, Morris RG. Synaptic plasticity and memory: an evaluation of the hypothesis. Annu Rev Neurosci 2000; 23: 649-711.
75. Brown RE, Milner PM. Te legacy of Donald O. Hebb: more than the Hebb synapse. Nat Rev 2003; 4: 1013-9.
76. Whitlock JR, Heynen AJ, Shuler MG, Bear MF. Learning induces long-term potentiation in the hippocampus. Science 2006; 313: 1093-7.
77. Yamazaki Y, Jia Y, Hamaue N, Sumikawa K. Nicotine-induced switch in the nicotinic cholinergic mechanisms of facilitation of long-term potentiation induction. Eur J Neurosci 2005; 22: 845- 60.
78. Lagostena L, Trocme-Thibierge C, Morain P, Cherubini E. The partial alpha7 nicotine acetylcholine receptor agonist S 24795 enhances long-term potentiation at CA3-CA1 synapses in the adult mouse hippocampus. Neuropharmacology 2008; 54: 676-85.
79. Alkondon M, Pereira EF, Almeida LE, Randall WR, Albuquerque EX. Nicotine at concentrations found in cigarette smokers activates and desensitizes nicotinic acetylcholine receptors in CA1 interneurons of rat hippocampus. Neuropharmacology 2000; 39: 2726-39.
80. Matsuyama S, Matsumoto A, Enomoto T, Nishizaki T. Activation of nicotinic acetylcholine receptors induces long-term potentiation in vivo in the intact mouse dentate gyrus. Eur J Neurosci 2000;12: 3741-7.
81. Nashmi R, Xiao C, Deshpande P, McKinney S, Grady SR, Whiteaker P, et al. Chronic nicotine cell specifcally upregulates functional alpha 4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path. J Neurosci 2007; 27: 8202-18.
82. Kauer JA, Malenka RC. Synaptic plasticity and addiction. Nat Rev 2007; 8: 844-58.
83. Saal D, Dong Y, Bonci A, Malenka RC. Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron 2003; 37: 577-82.
84. See RE. Neural substrates of conditioned-cued relapse to drug-seeking behavior. Pharmacol Biochem Behav 2002; 71: 517-29.
85. Dani JA, Harris RA. Nicotine addiction and comorbidity with alcohol abuse and mental illness. Nat Neurosci 2005; 8: 1465-70.
86. Slemmer JE, Martin BR, Damaj MI. Bupropion is a nicotinic antagonist. J Pharmacol Exp Ter 2000; 295: 321-7.
87. Coe JW, Brooks PR, Vetelino MG, Wirtz MC, Arnold EP, Huang J, et al. Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation. J Med Chem 2005; 48: 3474-7.
88. Mihalak KB, Carroll FI, Luetje CW. Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors. Mol Pharmacol 2006; 70: 801-5.
89. Frotscher M, Leranth C. Cholinergic innervation of the rat hippo campus as revealed by choline acetyltransferase immuno-cytochemistry: a combined light and electron microscopic study. J Compar Neurol 1985; 239: 237-46.